Targeting Neurogenesis in Seeking Novel Treatments for Ischemic Stroke.
Takayuki NagaseKyohei KinTakao YasuharaPublished in: Biomedicines (2023)
The interruption of cerebral blood flow leads to ischemic cell death and results in ischemic stroke. Although ischemic stroke is one of the most important causes of long-term disability and mortality, limited treatments are available for functional recovery. Therefore, extensive research has been conducted to identify novel treatments. Neurogenesis is regarded as a fundamental mechanism of neural plasticity. Therefore, therapeutic strategies targeting neurogenesis are thought to be promising. Basic research has found that therapeutic intervention including cell therapy, rehabilitation, and pharmacotherapy increased neurogenesis and was accompanied by functional recovery after ischemic stroke. In this review, we consolidated the current knowledge of the relationship between neurogenesis and treatment for ischemic stroke. It revealed that many treatments for ischemic stroke, including clinical and preclinical ones, have enhanced brain repair and functional recovery post-stroke along with neurogenesis. However, the intricate mechanisms of neurogenesis and its impact on stroke recovery remain areas of extensive research, with numerous factors and pathways involved. Understanding neurogenesis will lead to more effective stroke treatments, benefiting not only stroke patients but also those with other neurological disorders. Further research is essential to bridge the gap between preclinical discoveries and clinical implementation.
Keyphrases
- cerebral ischemia
- atrial fibrillation
- cell therapy
- neural stem cells
- subarachnoid hemorrhage
- brain injury
- cell death
- blood brain barrier
- healthcare
- cerebral blood flow
- stem cells
- type diabetes
- mesenchymal stem cells
- coronary artery disease
- cardiovascular disease
- cancer therapy
- cardiovascular events
- smoking cessation
- bone marrow
- risk factors
- ischemia reperfusion injury